Success Metrics

Clinical Success Rate
89.5%

Based on 17 completed trials

Completion Rate
89%(17/19)
Active Trials
15(26%)
Results Posted
12%(2 trials)
Terminated
2(3%)

Phase Distribution

Ph phase_2
1
2%
Ph not_applicable
24
41%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution25 total trials
Phase 2Efficacy & side effects
1(4.0%)
N/ANon-phased studies
24(96.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

85.0%

17 of 20 finished

Non-Completion Rate

15.0%

3 ended early

Currently Active

15

trials recruiting

Total Trials

58

all time

Status Distribution
Active(24)
Completed(17)
Terminated(3)
Other(14)

Detailed Status

Completed17
unknown14
Recruiting13
Not yet recruiting9
Active, not recruiting2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
58
Active
15
Success Rate
89.5%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (4.0%)
N/A24 (96.0%)

Trials by Status

withdrawn12%
not_yet_recruiting916%
completed1729%
active_not_recruiting23%
recruiting1322%
terminated23%
unknown1424%

Recent Activity

Clinical Trials (58)

Showing 20 of 58 trialsScroll for more
NCT07714941

EUS-Guided ATI and SWE in Individuals With Normal FibroScan

Not Yet Recruiting
NCT07449377Not Applicable

Evaluation of Fibroscan® Performance in Diagnosing Acute Heart Failure in Patients Presenting to the Emergency Department

Recruiting
NCT02575625Not Applicable

Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis

Completed
NCT07603817

Association Between Overt and Sub-clinical Primary Hypothyroidism and Metabolic Dysfunction-Associated Steatoic Liver Disease in Non-Diabetic Patients

Recruiting
NCT05861375

Liver Biomarkers in Anorexia Nervosa

Completed
NCT06877026Not Applicable

FibroScan-Reproducibility and Repeatability Study

Completed
NCT06477146Phase 2

Milk Thistle Clinical Trial in Pediatric NAFLD

Recruiting
NCT06445335Not Applicable

Prevalence of NAFLD in T2DM Patients

Active Not Recruiting
NCT01796145Not Applicable

Fibroscan Study in HCC

Active Not Recruiting
NCT07222813Not Applicable

Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)

Not Yet Recruiting
NCT07206004

Effect of Parenteral Support on FibroScan in Short Bowel Syndrome

Not Yet Recruiting
NCT06592820

Endoscopic Ultrasound Shear Wave Elastography Study

Recruiting
NCT07146815Not Applicable

PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease

Completed
NCT06757348

Fatty Liver and Pancreatic Steatosis

Not Yet Recruiting
NCT06445361Not Applicable

Prevalence of NAFLD in T1DM Patients

Recruiting
NCT07042360

Application of Comprehensive Non-invasive Assessment To Phenotype Tricuspid Regurgitation

Recruiting
NCT06960863

Fibroscan Evaluating Immunotherapy Response in Hepatocellular Carcinoma

Recruiting
NCT04807868

AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)

Recruiting
NCT06634160

Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia

Recruiting
NCT06739330

Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease

Recruiting

Drug Details

Intervention Type
PROCEDURE
Total Trials
58